Meesho Limited Allots 1,39,13,282 Equity Shares Under ESOP 2024 Plan

Meesho Limited has allotted 1,39,13,282 equity shares of face value Re. 1/- each to its eligible employees, pursuant to the exercise of vested options under the company's Employee Stock Option Plan, 2024 ("ESOP 2024 Plan"). The allotment was approved by the Nomination and Remuneration Committee of the Board of Directors through a circular resolution passed on May 04, 2026, and has been disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

ESOP Allotment Details

The allotted equity shares carry a face value of Re. 1/- each and shall rank pari-passu with the existing equity shares of the company in all respects. The key details of the allotment are summarised below:

Parameter: Details Date of Allotment: May 04, 2026 Number of Shares Allotted: 1,39,13,282 equity shares Face Value per Share: Re. 1/- Plan: ESOP 2024 Plan Approved By: Nomination and Remuneration Committee Mode of Approval: Circular Resolution

Impact on Share Capital

Following the allotment, the issued, subscribed, and paid-up equity share capital of Meesho Limited has been revised. The table below captures the change in share capital:

Metric: Before Allotment After Allotment Total Paid-up Capital (Rs.): Rs. 4,57,35,34,576 Rs. 4,58,74,47,858 Number of Equity Shares: 4,57,35,34,576 4,58,74,47,858 Face Value per Share: Re. 1/- Re. 1/-

The disclosure was made to both the National Stock Exchange of India Limited and BSE Limited in compliance with applicable listing regulations. The company has also indicated that the information will be made available on its investor relations website at https://investor.meesho.com/announcements . The allotment was signed off by Rahul Bhardwaj, Company Secretary & Compliance Officer (Membership No.: A41649), on behalf of Meesho Limited.

Meesho Limited has received an Order-in-Appeal from the Commissioner (Appeals), CGST Thane Commissionerate, upholding a significant tax demand of ₹14.29 crore. The company disclosed this development through a formal regulatory filing under Regulation 30 of the SEBI Listing Regulations on April 29, 2026.

Regulatory Disclosure and Order Details

The company informed both NSE and BSE about receiving the Order-in-Appeal passed under Section 107(11) of the Central Goods and Services Tax Act, 2017. The order was dated April 24, 2026, and received by the company on April 28, 2026.

Parameter: Details Tax Demand Amount: ₹14.29 crore (approximately) Order Date: April 24, 2026 Receipt Date: April 28, 2026 Period Covered: October 1, 2018 to March 31, 2020 Filing Date: April 29, 2026 Stock Symbols: NSE: MEESHO, BSE: 544632

The appellate authority upheld the tax demand along with applicable interest and penalty under Section 74 of the CGST Act. However, the penalty imposed under Section 122 of the CGST Act has been set aside by the appellate authority.

Nature of Tax Dispute

The order pertains to Tax Collected at Source (TCS) obligations under Section 52 of the CGST Act on transactions between resellers and end customers. The matter relates to Meesho's reseller business model, where individual resellers share products from the Meesho platform to their customers via social media channels.

Aspect: Details Violation Alleged: Non-collection of TCS under Section 52 Transaction Type: Reseller to end customer supplies Platform Context: Outside Meesho platform ecosystem Current TCS Practice: Company collecting TCS on platform supplies

The company clarified that it is appropriately collecting and depositing TCS on all supplies made by sellers to users through its platform. The dispute specifically relates to transactions occurring between resellers and their customers outside the platform.

Company's Legal Position and Response Strategy

Meesho has expressed strong disagreement with the appellate authority's decision. Based on detailed internal assessment and independent professional advice, the company maintains that the demand is unsustainable and without merit.

The company plans to file an appeal before the Goods and Services Tax Appellate Tribunal (GSTAT) within prescribed timelines and will vigorously pursue all legal remedies. Meesho remains highly confident of achieving a favorable outcome in this matter.

Financial and Business Impact Assessment

According to the regulatory disclosure, the order has no material adverse impact on Meesho's financial position, operations, business, or other activities. The company had previously disclosed this matter in its prospectus filed on December 5, 2025.

The formal communication was signed by Rahul Bhardwaj, Company Secretary & Compliance Officer, and included detailed annexures as required under SEBI Master Circular guidelines. The information has also been made available on the company's investor website for stakeholder transparency.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.